These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36604954)

  • 1. Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models.
    Jeon MJ; Haugen BR
    Endocrinol Metab (Seoul); 2022 Dec; 37(6):830-838. PubMed ID: 36604954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo mouse model of metastatic human thyroid cancer.
    Zhang L; Gaskins K; Yu Z; Xiong Y; Merino MJ; Kebebew E
    Thyroid; 2014 Apr; 24(4):695-704. PubMed ID: 24262022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates.
    Choi HR; Kim K
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers.
    Schweppe RE; Pozdeyev N; Pike LA; Korch C; Zhou Q; Sams SB; Sharma V; Pugazhenthi U; Raeburn C; Albuja-Cruz MB; Reigan P; LaBarbera DV; Landa I; Knauf JA; Fagin JA; Haugen BR
    Mol Cancer Res; 2019 May; 17(5):1036-1048. PubMed ID: 30733375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
    Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
    Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF.
    Antonello ZA; Nucera C
    Oncogene; 2014 Nov; 33(47):5397-404. PubMed ID: 24362526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of thyroid cancer: A 2015 update.
    Kirschner LS; Qamri Z; Kari S; Ashtekar A
    Mol Cell Endocrinol; 2016 Feb; 421():18-27. PubMed ID: 26123589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from mouse models of thyroid cancer.
    Kim CS; Zhu X
    Thyroid; 2009 Dec; 19(12):1317-31. PubMed ID: 20001715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
    Zitzelsberger H; Thomas G; Unger K
    Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death from thyroid cancer of follicular cell origin.
    Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
    J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Horm Metab Res; 2022 Jan; 54(1):7-11. PubMed ID: 34758495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next generation of orthotopic thyroid cancer models: immunocompetent orthotopic mouse models of BRAF V600E-positive papillary and anaplastic thyroid carcinoma.
    Vanden Borre P; McFadden DG; Gunda V; Sadow PM; Varmeh S; Bernasconi M; Jacks T; Parangi S
    Thyroid; 2014 Apr; 24(4):705-14. PubMed ID: 24295207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.
    Pringle DR; Vasko VV; Yu L; Manchanda PK; Lee AA; Zhang X; Kirschner JM; Parlow AF; Saji M; Jarjoura D; Ringel MD; La Perle KM; Kirschner LS
    J Clin Endocrinol Metab; 2014 May; 99(5):E804-12. PubMed ID: 24512487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.
    Maniakas A; Henderson YC; Hei H; Peng S; Chen Y; Jiang Y; Ji S; Cardenas M; Chiu Y; Bell D; Williams MD; Hofmann MC; Scherer SE; Wheeler DA; Busaidy NL; Dadu R; Wang JR; Cabanillas ME; Zafereo M; Johnson FM; Lai SY
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4652-e4665. PubMed ID: 34147031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.
    Penna GC; Pestana A; Cameselle JM; Momesso D; de Andrade FA; Vidal APA; Araujo Junior ML; Melo M; Fernandes PV; Corbo R; Vaisman M; Sobrinho-Simões M; Soares P; Vaisman F
    Endocrine; 2018 Sep; 61(3):489-498. PubMed ID: 29948935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics.
    Jin Y; Liu M; Sa R; Fu H; Cheng L; Chen L
    Cancer Lett; 2020 Jan; 469():35-53. PubMed ID: 31589905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
    Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
    Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
    Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
    Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation.
    Li Q; Liu W; Wang Z; Wang C; Ai Z
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34779491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin.
    Fallahi P; Ferrari SM; Elia G; Ragusa F; Patrizio A; Paparo SR; Marone G; Galdiero MR; Guglielmi G; Foddis R; Cristaudo A; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():203-216. PubMed ID: 32569821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.